2011;32:1147 57. S3.9-4. Lin AE, Basson CT, Goldmuntz E, et al. Adults with genetic syn- dromes and cardiovascular abnormalities: clinical history and man- agement. Genet Med. 2008;10:469 94. S3.9-5. Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol. 1998;32:492 8. S3.9-6. Richards AA, Garg V. Genetics of congenital heart disease. Curr Cardiol Rev. 2010;6:91 7. S3.9-7. Kitsiou-Tzeli S, Kolialexi A, Fryssira H, et al. Detection of 22q11.2 deletion among 139 patients with Di George/velocardiofacial syn- drome features. In Vivo. 2004;18:603 8. S3.9-8. Bassett AS, Chow EWC, Husted J, et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A. 2005;138:307 13. S3.9-9. Barisic I, Boban L, Greenlees R, et al. Holt Oram syndrome: a regis- try-based study in Europe. Orphanet J Rare Dis. 2014;9:156. S3.9-10. Pierpont MEM, Magoulas PL, Adi S, et al. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2014;134:e1149 62. 3.10. Acquired Cardiovascular Disease S3.10-1. Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult con- genital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005;26:2325 33. S3.10-2. Pillutla P, Shetty KD, Foster E. Mortality associated with adult con- genital heart disease: trends in the US population from 1979 to 2005 Am Heart J. 2009;158:874 9. S3.10-3. Stuart AG. Changing lesion demographics of the adult with con- genital heart disease: an emerging population with complex needs. Future Cardiol. 2012;8:305 13. S3.10-4. Tutarel O, Kempny A, Alonso-Gonzalez R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35:725 32. S3.10-5. 